Royalty Monetizations

Covington’s Finance Royalty Monetizations practice is built on decades of experience advising both buyers and sellers in transactions that unlock the value of future revenue streams. We have been active in this specialized market since its earliest stages, helping clients structure both traditional and synthetic royalty monetizations across pharmaceuticals, biotechnology, medical devices, and consumer products. Our team combines deep knowledge of structured finance, licensing, regulatory, intellectual property, and tax considerations, ensuring that every deal is crafted to meet strategic objectives while avoiding common pitfalls.

Covington’s team is set apart by our ability to integrate transactional drivers with sector specific expertise. Clients rely on us not only for our technical proficiency but also for our ability to translate diligence findings into practical negotiating strategies. Whether advising investment firms on royalty purchases, structuring synthetic financings for emerging biotech companies, or guiding families and artists through monetizations of music and media rights, we bring unmatched insight into the complexities of royalty transactions. Our multidisciplinary approach yields effective, commercially sound transactions in one of the most dynamic areas of modern finance.